Loading the section…

BMEA: financial statements from SEC — TradeAlmanac

BMEA

Biomea Fusion, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Research and development	9M	14M	17M	23M	25M	27M	32M
Selling, general and administrative	4M	4M	5M	7M	5M	7M	7M
Operating expenses	13M	21M	21M	30M	30M	34M	39M
Operating income	−13M	−21M	−21M	−30M	−30M	−34M	−39M
Net income	−12M	−16M	−21M	−29M	−29M	−33M	−37M
Earnings per share	−0.17	−0.27	−0.51	−0.80	−0.81	−0.91	−1.03
Earnings per share, diluted	−0.17	−0.27	−0.51	−0.80	−0.81	−0.91	−1.03
Weighted average shares	72M	60M	41M	37M	36M	36M	36M
Weighted average shares, diluted	72M	60M	41M	37M	36M	36M	36M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	45M	56M	47M	56M	36M	58M	88M	113M
Current assets	46M	58M	49M

Cash flow

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	−12M	—	—	−26M	—	—
Depreciation and amortisation	46,000	400,000	500,000	468,000

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator